PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 89 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $61,334 | -47.2% | 23,321 | -29.1% | 0.00% | – |
| Q2 2023 | $116,151 | -29.3% | 32,904 | -38.1% | 0.00% | – |
| Q1 2023 | $164,243 | +46.5% | 53,153 | +100.6% | 0.00% | – |
| Q4 2022 | $112,078 | -21.6% | 26,496 | -56.3% | 0.00% | – |
| Q3 2022 | $143,000 | -27.8% | 60,677 | -12.9% | 0.00% | – |
| Q2 2022 | $198,000 | +44.5% | 69,697 | +47.2% | 0.00% | – |
| Q1 2022 | $137,000 | -15.4% | 47,337 | -11.3% | 0.00% | – |
| Q4 2021 | $162,000 | -92.1% | 53,392 | -81.8% | 0.00% | – |
| Q3 2021 | $2,059,000 | -19.0% | 293,877 | +6.1% | 0.00% | – |
| Q2 2021 | $2,543,000 | -36.0% | 277,036 | -32.2% | 0.00% | – |
| Q1 2021 | $3,973,000 | +56.3% | 408,709 | +65.0% | 0.00% | – |
| Q4 2020 | $2,542,000 | +53.3% | 247,678 | +50.8% | 0.00% | – |
| Q3 2020 | $1,658,000 | -41.8% | 164,288 | -39.9% | 0.00% | – |
| Q2 2020 | $2,851,000 | +224.0% | 273,304 | +162.5% | 0.00% | – |
| Q1 2020 | $880,000 | -63.7% | 104,119 | -62.4% | 0.00% | – |
| Q4 2019 | $2,427,000 | +2.2% | 277,260 | +25.6% | 0.00% | – |
| Q3 2019 | $2,375,000 | -60.4% | 220,724 | -53.2% | 0.00% | -100.0% |
| Q2 2019 | $5,998,000 | -69.5% | 471,965 | -7.0% | 0.00% | -66.7% |
| Q1 2019 | $19,694,000 | +136.5% | 507,724 | +24.0% | 0.00% | +200.0% |
| Q4 2018 | $8,329,000 | -54.1% | 409,315 | +3.3% | 0.00% | -66.7% |
| Q3 2018 | $18,161,000 | -10.8% | 396,107 | +15.0% | 0.00% | -25.0% |
| Q2 2018 | $20,366,000 | -11.6% | 344,305 | +1.7% | 0.00% | 0.0% |
| Q1 2018 | $23,035,000 | -19.5% | 338,506 | +16.9% | 0.00% | -20.0% |
| Q4 2017 | $28,613,000 | +10.0% | 289,449 | +33.2% | 0.01% | +25.0% |
| Q3 2017 | $26,023,000 | +10.8% | 217,313 | -19.1% | 0.00% | -20.0% |
| Q2 2017 | $23,491,000 | +260.7% | 268,768 | +53.5% | 0.01% | +400.0% |
| Q1 2017 | $6,513,000 | -34.0% | 175,070 | -45.5% | 0.00% | -50.0% |
| Q4 2016 | $9,867,000 | -50.4% | 321,370 | +8.3% | 0.00% | -50.0% |
| Q3 2016 | $19,887,000 | +150.5% | 296,607 | +11.3% | 0.00% | +100.0% |
| Q2 2016 | $7,938,000 | +64.9% | 266,479 | +62.5% | 0.00% | +100.0% |
| Q1 2016 | $4,815,000 | -77.8% | 163,939 | -40.6% | 0.00% | -80.0% |
| Q4 2015 | $21,655,000 | +41.6% | 276,211 | +36.1% | 0.01% | +66.7% |
| Q3 2015 | $15,298,000 | -22.2% | 203,010 | +20.5% | 0.00% | -50.0% |
| Q2 2015 | $19,669,000 | +1.3% | 168,473 | +104.9% | 0.01% | -14.3% |
| Q1 2015 | $19,411,000 | +233.1% | 82,212 | +167.0% | 0.01% | +250.0% |
| Q4 2014 | $5,828,000 | -43.7% | 30,790 | -29.0% | 0.00% | -33.3% |
| Q3 2014 | $10,351,000 | +256.2% | 43,385 | -1.5% | 0.00% | +200.0% |
| Q2 2014 | $2,906,000 | -48.4% | 44,033 | -18.6% | 0.00% | -50.0% |
| Q1 2014 | $5,631,000 | -5.0% | 54,075 | -5.6% | 0.00% | 0.0% |
| Q4 2013 | $5,929,000 | +61.6% | 57,271 | -16.3% | 0.00% | +100.0% |
| Q3 2013 | $3,670,000 | -14.7% | 68,400 | -29.5% | 0.00% | -50.0% |
| Q2 2013 | $4,304,000 | – | 96,991 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $5,108,000 | 2.15% |
| Camber Capital Management LP | 4,235,000 | $12,070,000 | 0.52% |
| Kynam Capital Management, LP | 579,915 | $1,653,000 | 0.42% |
| GLOBEFLEX CAPITAL L P | 419,322 | $1,195,000 | 0.29% |
| Eversept Partners, LP | 1,435,077 | $4,089,969 | 0.29% |
| ARMISTICE CAPITAL, LLC | 1,500,000 | $4,275,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 506,066 | $1,442,000 | 0.07% |
| XTX Topco Ltd | 36,130 | $103,000 | 0.04% |
| State of Wyoming | 20,732 | $59,000 | 0.04% |
| Patriot Financial Group Insurance Agency, LLC | 55,500 | $158,000 | 0.03% |